⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL645100 | 0.93 | — | — | |
| SCHEMBL1567 | 0.93 | — | — | |
| SCHEMBL331 | 0.86 | — | — | |
| SCHEMBL732100 | 0.86 | — | — | |
| SCHEMBL1370459 | 0.86 | — | — | |
| Water SCHEMBL647336 | 0.86 | — | — | |
| SCHEMBL10535380 | 0.86 | — | — | |
| Phosphine SCHEMBL11344163 | 0.86 | — | — | |
| SCHEMBL3648065 | 0.86 | — | — | |
| SCHEMBL4133917 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117209361-A | Bisphenol F preparation method | 山东富宇石化有限公司 | 2023-12-12 | — | — | CN | claimed |
| US-20180208543-A1 | NEW METHOD FOR SYNTHESIS OF FENFLURAMINE, AND NEW COMPOSITIONS COMPRISING IT | FRAU PHARMA S.R.L. (IT) | 2018-07-26 | — | — | US | claimed |
| CN-106852501-A | A kind of purposes of clam extract | 浙江海洋大学 | 2017-06-16 | — | — | CN | claimed |
| CN-106854671-A | A kind of preparation method of clam antineoplastic extract | 浙江海洋大学 | 2017-06-16 | — | — | CN | claimed |
| EP-3170807-A1 | NEW METHOD FOR SYNTHESIS OF FENFLURAMINE, OF ISOMERS THEROF AND/OR OF ANALOGS THEREOF, AND NEW COMPOSITIONS COMPRISING IT | Frau Pharma S.r.l. (IT) | 2017-05-24 | — | — | EP | claimed |
| EP-0746324-A1 | METHOD OF COMBATTING OSTEOPOROSIS AND OTHER DISEASE STATES IN MAMMALIAN SUBJECTS, UTILIZING ORGANIC BORON COMPOUNDS | BORON BIOLOGICALS, INC. (US) | 1996-12-11 | — | — | EP | claimed |
| US-5312816-A | Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds | BORON BIOLOGICALS, INC. (US) | 1994-05-17 | — | — | US | claimed |
| EP-0583394-A4 | — | — | 1994-04-27 | — | — | EP | claimed |
| EP-0583394-A1 | PHOSPHITE-BORANE COMPOUNDS, AND METHOD OF MAKING AND USING THE SAME | BORON BIOLOGICALS, INC. (US) | 1994-02-23 | — | — | EP | claimed |
| WO-1993005795-A1 | METHOD OF COMBATTING OSTEOPOROSIS AND OTHER DISEASE STATES IN MAMMALIAN SUBJECTS, UTILIZING ORGANIC BORON COMPOUNDS | BORON BIOLOGICALS, INC. (US) | 1993-04-01 | — | — | WO | claimed |
| WO-1992020650-A2 | PHOSPHITE-BORANE COMPOUNDS, AND METHOD OF MAKING AND USING THE SAME | BORON BIOLOGICALS, INC. (US) | 1992-11-26 | — | — | WO | claimed |
| CN-117209361-B | Bisphenol F preparation method | 山东富宇石化有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-117209361-A | Bisphenol F preparation method | 山东富宇石化有限公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2021256061-A1 | PLATINUM-TUNGSTEN SOLID SOLUTION PARTICLES AND CATALYST CONTAINING SAME | 日本曹達株式会社 | 2021-12-23 | — | — | WO | disclosed |
| US-20180208543-A1 | NEW METHOD FOR SYNTHESIS OF FENFLURAMINE, AND NEW COMPOSITIONS COMPRISING IT | FRAU PHARMA S.R.L. (IT) | 2018-07-26 | — | — | US | disclosed |
| US-4301129-A | BY TREATING AN INORGANIC CYANIDE WITH A BORON TRIFLUORIDE DONOR | THIOKOL CORPORATION (US) | 1981-11-17 | — | — | US | disclosed |
| US-4209510-A | ANTIARTHRITIC, ANALGESIC, ANTIINFLAMMATORY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1980-06-24 | — | — | US | disclosed |
| US-4209510-A | ANTIARTHRITIC, ANALGESIC, ANTIINFLAMMATORY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1980-06-24 | — | — | US | disclosed |
| EP-0009382-A1 | Production of cyanoborohydrides | THIOKOL CORPORATION (US) | 1980-04-02 | — | — | EP | disclosed |
| US-3873621-A | Method for preparing amines | UNIV MINNESOTA | 1975-03-25 | — | — | US | disclosed |